Using a PET scan to choose the best tumor for TIL therapy
Part of Cancer, Immune system & allergy clinical trials.
This study tests whether a special PET scan can help doctors choose the best tumor spot to remove for TIL therapy, which uses your own immune cells to fight melanoma. It may improve treatment outcomes by selecting the most effective immune cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced melanoma and are already eligible to receive TIL therapy (tumor-infiltrating lymphocytes), a treatment using your own immune cells.
- You have at least two measurable tumor spots, and one of them can be removed with a minor surgery (not in the belly or pelvis).
- You are 18 years or older.
- You are willing to use effective birth control during the study if you or your partner could become pregnant.
- You can understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests GC101 TIL, a treatment made from your own melanoma tumor cells, for advanced melanoma. It may help the immune system better fight the cancer after standard treatments have already stopped working or if none are available.
This trial studies a treatment called TIL therapy, which uses your own immune cells grown from a tumor sample, to treat advanced cancers of the liver/bile ducts or pancreas. It’s mainly for people whose standard treatments have already failed (or none exist), and who can safely provide tumor tissue for the cell preparation.
This trial tests a new way to guide treatment with your own immune cells (called TIL therapy) using a special PET scan to see which tumors might respond best. It aims to make the treatment more effective for people with advanced melanoma that has not responded to previous therapies.
This trial tests a new T-cell therapy made from your own tumor (TILs), genetically edited to remove the PD1 checkpoint blocker. It may help your immune system fight melanoma that has not responded to standard treatments like anti-PD1 therapy.
This trial tests a treatment called tumor-infiltrating lymphocyte (TIL) therapy for people with advanced melanoma that has not responded to immune checkpoint inhibitors. TIL therapy uses your own immune cells to fight the cancer. The study aims to see if this can help shrink tumors or slow the disease.
This study tests a new type of cell therapy made from your own immune cells (called TILs) to see if it can shrink tumors better than standard chemotherapy in people with advanced melanoma that has stopped responding to immunotherapy. If you qualify, you may have a chance to try a personalized treatment that uses your body's own defenses to fight the cancer.
Hear when a new Advanced Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.